Approved Pathway for Biosimilars Must Be Patient-Focused
The U.S. pharmaceutical industry has worked hard to become an international leader in the production of biotech drugs. But as the nation introduces these medicines, we need to ensure that safety protocols are in place -- so that every patient has the opportunity to get healthy.
approve pathway biosimilars patient focused  USA  pharmaceutical industry work hard international leader production biotech drug nation introduce medicine need ensure safety protocol place patient opportunity healthy